Presentations from 30th Annual International Prostate Cancer Update

SESSION 1: MEN’S UROLOGIC HEALTH – Taking Control of Your Prostate Cancer Fate

State of the Art: Nutrition and Prostate Cancer

Mark A. Moyad, MD, MPH, presented this lecture during the 30th Annual International Prostate Cancer Update on January 23, 2020, in Avon, Colorado.

Ethnic Disparities in Sexual Dysfunction Outcomes After Prostate Cancer Treatment: Myth or Reality?

Arthur L. Burnett II, MD, MBA, FACS, presented this lecture during the 30th Annual International Prostate Cancer Update on January 23, 2020, in Avon, Colorado.

Urinary Health Issues Following Treatment for Prostate Cancer

Ryan P. Terlecki, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 23, 2020, in Avon, Colorado.

The Prostate – Most Diseased Organ in the Male Body

Ryan P. Terlecki, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 23, 2020, in Avon, Colorado.

Exercise and Prostate Cancer: Prevention and Bettering Outcomes in Both Localized and Advanced Prostate Cancer

Arturo Mendoza-Valdes, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 23, 2020, in Avon, Colorado.

Sarcopenia in the Prostate Cancer Patient

Mark A. Moyad, MD, MPH, presented this lecture during the 30th Annual International Prostate Cancer Update on January 23, 2020, in Avon, Colorado.

The Role of Genetic Testing in Prostate Cancer

A. Karim Kader, MD, PhD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 23, 2020, in Avon, Colorado.

An Update in Patient Advocacy Impact

Wendy L. Poage, MHA, presented this lecture during the 30th Annual International Prostate Cancer Update on January 23, 2020, in Avon, Colorado.

SESSION 2: UROLOGY GROUP PRACTICE MANAGEMENT – LUGPA Lecture Series

The Present and Future of LUGPA

Richard G. Harris, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 23, 2020, in Avon, Colorado.

Managing a Clinical Research Program in 2020

Evan R. Goldfischer, MD, MBA, CPI, FACS, presented this lecture during the 30th Annual International Prostate Cancer Update on January 23, 2020, in Avon, Colorado.

Advanced Prostate Cancer: What’s Changing

Richard G. Harris, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 23, 2020, in Avon, Colorado.

Telemedicine and Prostate Cancer

Evan R. Goldfischer, MD, MBA, CPI, FACS, presented this lecture during the 30th Annual International Prostate Cancer Update on January 23, 2020, in Avon, Colorado.

Physician Burnout: Facts, Fiction, and Fixes

Peter M. Knapp, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 23, 2020, in Avon, Colorado.

Prostate Biopsy and Imaging Controversies

Neal D. Shore, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 23, 2020, in Avon, Colorado.

SESSION 3: THE MICROBIOME AND PROSTATE CANCER – An Evolving Story

Infection and Prostate Cancer “The Old Story”

J. Curtis Nickel, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 23, 2020, in Avon, Colorado.

NGS+PCR – The Key to Clearing Chronic Urological Infections

Rick Martin, presented this lecture during the 30th Annual International Prostate Cancer Update on January 23, 2020, in Avon, Colorado.

Next Generation Sequencing of Microbiomes in Urine Samples of Prostate Cancer Patients

Priya N. Werahera, PhD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 23, 2020, in Avon, Colorado.

SESSION 4: GENETICS AND GENOMIC BIOMARKERS

Next Generation Biomarkers—As Reflex, Combination, or First Line?

E. David Crawford, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 24, 2020, in Avon, Colorado.

Improving Specificity of PSA Screening with Serum and Urine Markers – Who Doesn’t Need a Prostate Biopsy

Daniel W. Lin, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 24, 2020, in Avon, Colorado.

Genetics and Genomic Biomarkers: How Molecular Markers and mpMRI Play a Role

R. Jonathan Henderson, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 24, 2020, in Avon, Colorado.

What Role Do Markers Play in Establishing AS or Definitive Care?

Gerald L. Andriole, Jr., MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 24, 2020, in Avon, Colorado.

Clinical Implications of Genetics in Prostate Cancer

A. Karim Kader, MD, PhD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 24, 2020, in Avon, Colorado.

Treating a Patient Denied Coverage Based on Not Conforming to NCCN Guidelines

James L. Mohler, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 24, 2020, in Avon, Colorado.

SESSION 5: TRIFECTA OF CARE – Panel Discussion on Integration of Stakeholders in HealthCare

Panel Discussion on Integration of Stakeholders in Healthcare: Academic Urology

Christopher J. Kane, MD, FACS, presented this lecture during the 30th Annual International Prostate Cancer Update on January 24, 2020, in Avon, Colorado.

Panel Discussion on Integration of Stakeholders in Healthcare: The Group Practice Experience

Edward S. Cohen, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 24, 2020, in Avon, Colorado.

Panel Discussion on Integration of Stakeholders in Healthcare: The Kaiser Permanente Experience

Eugene Y. Rhee, MD, MBA, presented this lecture during the 30th Annual International Prostate Cancer Update on January 24, 2020, in Avon, Colorado.

Panel Discussion on Integration of Stakeholders in Healthcare: The Small Group Practice Experience

Garrett D. Pohlman, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 24, 2020, in Avon, Colorado.

SESSION 6: UPDATE ON BRACHYTHERAPY FOR PROSTATE CANCER

Update on Brachytherapy for the Treatment of Prostate Cancer in 2020

Moderator: Peter J. Rossi, MD
Co-presenters: Peter J. Rossi, MD & Steven J. Frank, MD
Panelists: E. David Crawford, MD & Steven J. Frank, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 24, 2020, in Avon, Colorado.

SESSION 7: ANDROGEN DEPRIVATION THERAPY

Androgen Deprivation Therapy: A Closer Review of the Role of Anti-Androgens

Thomas E. Keane, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 24, 2020, in Avon, Colorado.

Panel on Androgen Deprivation Therapy: A Closer Review of the Cardiovascular Risk

Thomas E. Keane, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 24, 2020, in Avon, Colorado.

Challenging Cases in Advanced Prostate Cancer- mHSPC

E. David Crawford, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 24, 2020, in Avon, Colorado.

SESSION 8: ADVANCES IN IMAGING

Accuracy of ExactVu™ Micro-Ultrasound for Diagnosis of Prostate Cancer

Priya N. Werahera, PhD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 25, 2020, in Avon, Colorado.

29 MHz High Resolution Micro-Ultrasound:Improving Real-Time Targeting of Prostate Biopsies

Neal D. Shore, MD, FACS, presented this lecture during the 30th Annual International Prostate Cancer Update on January 25, 2020, in Avon, Colorado.

High Resolution Micro-Ultrasound for PCa Detection and Surveillance

Laurence Klotz, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 25, 2020, in Avon, Colorado.

MRI-Guided Transurethral Ultrasound Ablation (TULSA) in Patients with Localized Prostate Cancer

Laurence Klotz, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 25, 2020, in Avon, Colorado.

Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know

Jelle Barentsz, MD, PhD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 25, 2020, in Avon, Colorado.

SESSION 9: DISEASE STATE CASES/PRESENTATIONS

Case 1- Androgen Deprivation Therapy

Neal D. Shore, MD, FACS, was the moderator for this lecture during the 30th Annual International Prostate Cancer Update on January 25, 2020, in Avon, Colorado.

Case 2- Challenging Cases in Advanced Prostate Cancer: nmCRPC

R. Jonathan Henderson, MD, was the moderator for this lecture during the 30th Annual International Prostate Cancer Update on January 25, 2020, in Avon, Colorado.

SESSION 10: RAPID FIRE DISEASE STATE Cases/Presentations

New Concepts in Cavernous Nerve Localization and Functional Recovery after Radical Prostatectomy

Arthur L. Burnett II, MD, MBA, FACS, presented this lecture during the 30th Annual International Prostate Cancer Update on January 25, 2020, in Avon, Colorado.

Molecular Imaging For Staging and Advanced Disease – Axumin and PSMA

Robert E Reiter, MD, MBA, presented this lecture during the 30th Annual International Prostate Cancer Update on January 25, 2020, in Avon, Colorado.

New Approaches to Combining Brachytherapy with Immunotherapy

Steven E. Finkelstein, MD, FACRO, presented this lecture during the 30th Annual International Prostate Cancer Update on January 25, 2020, in Avon, Colorado.

Changing Landscape of mHSPC: New Approaches to an Old Problem

Michael S. Cookson, MD, MMHC, presented this lecture during the 30th Annual International Prostate Cancer Update on January 25, 2020, in Avon, Colorado.

SESSION 11: RAPID FIRE DISEASE STATE Cases/Presentations

The Backdoor Pathway for Intracrine Androgen Metabolism: New Targets for Treatment Directed Against Androgen Receptor Action (A Better Abiraterone)

James L. Mohler, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 26 2020, in Avon, Colorado.

Prognostic factors in hormone naïve metastatic prostate cancer (HNMPC)

Daisaku Hirano, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 26, 2020, in Avon, Colorado.

Treating a Patient Denied Coverage Based on Not Conforming to NCCN Guidelines

James L. Mohler, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 26 2020, in Avon, Colorado.

SESSION 12: PCA CLINICAL TRIAL UPDATES – An Outlook for 2020

Immunotherapy Trials

Daniel P. Petrylak, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 26 2020, in Avon, Colorado.

Theranostics/Radiopharmaceutical Trials

Daniel P. Petrylak, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 26 2020, in Avon, Colorado.

Anti-Androgen Trials

Daniel P. Petrylak, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 26 2020, in Avon, Colorado.

Chemotherapy Trials

Daniel P. Petrylak, MD, presented this lecture during the 30th Annual International Prostate Cancer Update on January 26 2020, in Avon, Colorado.